m+Medelevator.RU
← Поиск публикаций
Journal of proteome research · 2026

Cerebrospinal Fluid Proteome Reveals Dysregulation of Lysosomal and Axonal Proteins in Neurosyphilis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Tang Huayang, Hu Junjie, Wu Yifan, Gao Jinping, Wang Wenjun, Zheng Xiaodong, Zhang Ran, Liang Bo, Zhou Fusheng, Guo Ze

Аннотация

Neurosyphilis (NS), caused by Treponema pallidum, results in irreversible neurological damage. This study elucidated NS pathogenesis via cerebrospinal fluid (CSF) proteomic analysis comparing NS, suspected neurosyphilis (spNS), and non-neurosyphilis (nNS) controls by using liquid chromatography-tandem mass spectrometry (LC-MS/MS), public data set PXD033034, and ELISA validation. Of 1261 quantified proteins in the CSF, 234 were differentially expressed in NS, with 189 downregulated and enriched in lysosomal, axon guidance, and neurodegeneration pathways. Three previously identified CSF biomarkers of neurosyphilis, i.e., SEMA7A, SERPINA3, and ITIH4, were replicated. Key proteins in the lysosome pathway, including PSAP, CTSL, NPC2, and DNASE2, were significantly downregulated in the CSF of NS patients, and spNS patients presented a high CSF IgG index (spNS-hi-IgG-i). We also identified EPHA4, a key protein in the axon guidance pathway, as significantly downregulated in the CSF of NS patients. A positive correlation between PSAP and EPHA4 suggested a potential impact of lysosomal function on axonostasis in NS. ROC analysis revealed PSAP and DNASE2 as potential biomarkers for assessing neurodegeneration in NS and spNS-hi-IgG-i. These findings suggest that disruptions in lysosomal and axonal processes may contribute to neurodegeneration in NS, and the identified biomarkers hold potential as diagnostic indicators and therapeutic targets.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты